Grab is presented as a quality business with long-term potential, but its recent underperformance highlights opportunity cost and the importance of correct pricing and realistic expectations.
Source Post
4 Stocks I’d Sell Before This Gets Worse
Jun 17, 2026
The creator discusses a framework for evaluating stock positions, focusing on four buckets: opportunity cost/valuation disconnect, dead money/deterioration, expensive execution, and overvaluation/high expectations. The video uses Tesla and Apple as examples to illustrate these concepts, questioning whether their current valuations justify the growth and profitability, suggesting that capital might be better allocated elsewhere.
Linked Mentions
Tickers discussed in this post
AST SpaceMobile is considered overvalued, worth tens of billions with little revenue, making it prone to crashes on any missed targets.
Rocket Lab is identified as overvalued, trading at 50 times sales, which is not normal and suggests paying for many years of future execution.
Arm Holdings is mentioned as a high-quality business that is very expensive with high expectations, suggesting it might be a sell candidate if growth decelerates.
CrowdStrike is mentioned as a high-quality business that is very expensive with high expectations, suggesting it might be a reason to sell if growth decelerates.
PayPal is cited as a failure due to poor execution despite a cheap valuation, with management not being transparent, leading to a negative outcome.
Intel is presented as a turnaround story that has started to happen with the stock and business, but its current valuation is high and relies on future growth to be justified.
Nike is mentioned as a potential turnaround story with no recent growth, and while it might appear cheap, its valuation is questionable compared to faster-growing companies.
Axon is mentioned as a great business that has experienced a significant price decline due to its high premium valuation, despite solid execution.
Shopify is highlighted as a great business that has seen a significant decline due to trading at a high premium, making it a potential "dead money" investment.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.